Gabriel Millan Camacho

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.

Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The company is based in Singapore, Singapore.

Global Alliance on Vaccines & Immunization (Gavi) is an international organization that was established in 2000. Gavi's headquarters are located in Geneva, Switzerland, and it operates in over 70 countries worldwide. The organization's main objective is to enhance access to new and underused vaccines for children residing in the poorest countries worldwide.